IDXG OTC
Interpace Biosciences, Inc.
1W: -6.4%
1M: -17.2%
3M: -27.3%
YTD: +0.8%
1Y: +46.3%
3Y: +14.3%
5Y: -87.0%
$6.00
-0.39 (-6.10%)
Weekly Expected Move ±6.7%
$5
$6
$6
$6
$7
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$36M
Revenue
-20.3% YoY
$24M
Net Income
+372.0% YoY
$4M
Free Cash Flow
-2.4% YoY
61.9%
Gross Margin
3.5%
Op. Margin
1.7%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE221.9%
ROA104.3%
ROIC123.7%
Valuation
P/E0.2
P/B1.4
EV/EBITDA8.8
Leverage
Debt/Equity0.04
Current Ratio2.22
Interest Cov.98.3x
Quality Scores
Piotroski F6/9
Altman Z-4.47
Beneish M67.07